Status:
COMPLETED
EUS-guided Biliary Drainage vs. ERCP Assisted Transpapillary Drainage for Malignant Biliary Obstruction
Lead Sponsor:
First People's Hospital of Hangzhou
Conditions:
Malignant Biliary Obstruction
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Purpose of the study: To compare efficacy, stent patency, re-intervention rate, cost, quality of life, survival time, and adverse events between EUS-guide biliary drainage (EUS-BD) and ERCP assisted t...
Detailed Description
ERCP is a well-established procedure for the management of malignant biliary obstruction. However, even in expert hands, ERCP fails in 3%-5% of cases, especially in patients with surgically altered an...
Eligibility Criteria
Inclusion
- age: 18 - 85 years
- a patients who had malignant biliary obstruction confirmed by imaging examinations and Pathological examination
- Hyperbilirubinemia (total bilirubin \>= 1.5 mg/dl)
- inoperable state
- patients who agree to join this study
Exclusion
- a patients who cannot endure sedation or therapeutic endoscopic procedure
- a patients with bleeding tendency (PT \> 1.5 INR, PLT \< 50,000)
- patients underwent biliary drainage by surgery, ERCP or percutaneous transhepatic biliary drainage
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 15 2023
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT03812250
Start Date
January 1 2019
End Date
February 15 2023
Last Update
February 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hangzhou First People's Hospital
Hangzhou, China